1,585
Views
0
CrossRef citations to date
0
Altmetric
Influenza – Research Paper

Explorative study regarding influenza vaccine hesitancy among HIV-infected patients

ORCID Icon, , , , , ORCID Icon, & show all
Article: 2046434 | Received 27 Nov 2021, Accepted 22 Feb 2022, Published online: 31 Mar 2022

References

  • Budd A, Blanton L, Grohskopf L, Campbell A, Dugan VD, Wentworth E, Brammer L Surveillance Manual - Chapter 6: Influenza [Internet]. [accessed 2022 Sep 14]. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt06-influenza.html .
  • Italian Ministry of Health. Ministero della Salute DIREZIONE GENERALE DELLA PREVENZIONE SANITARIA Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2020-2021 [Internet]. [accessed 2021 Sep 14]. https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2020&codLeg=74451&parte=1%20&serie=null .
  • Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, Dawood H, Chhagan M, Haffejee S, Variava E, et al. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PloS One. 2015;10:e0118884. doi:10.1371/journal.pone.0118884.
  • González Álvarez DA, López Cortés LF, Cordero E. Impact of HIV on the severity of influenza. Expert Rev Respir Med. 2016;10:463–7. doi:10.1586/17476348.2016.1157474.
  • Crum-Cianflone NF, Iverson E, Defang G, Blair PJ, Eberly LE, Maguire J, Ganesan A, Faix D, Duplessis C, Lalani T, et al. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine. 2011;29:3183–91. doi:10.1016/j.vaccine.2011.02.040.
  • Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009;9:493–504. doi:10.1016/S1473-3099(09)70175-6.
  • Ryom L, Cotter A, de Miguel R, Béguelin C, Podlekareva D, Arribas JR, Marzolini C, Mallon P, Rauch A, Kirk O, et al. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. HIV Med. 2020;21:617–24. doi:10.1111/hiv.12878.
  • Sticchi L, Bruzzone B, Caligiuri P, Rappazzo E, Lo Casto M, de Hoffer L, Gustinetti G, Viscoli C, di Biagio A. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients. Hum Vaccines Immunother. 2015;11:263–69. doi:10.4161/hv.36162.
  • World Health Organization (WHO). Report of the sage working group on vaccine hesitancy [Internet]. 2014 [accessed 2022 Jan 24]. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf .
  • World Health Organization (WHO). Ten Threats to global health in 2019 [Internet]. 2019 [accessed 2022 Jan 24] . https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
  • Dini G, Toletone A, Sticchi L, Orsi A, Bragazzi NL, Durando P. Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature. Hum Vaccines Immunother. 2018;14:772–89. doi:10.1080/21645515.2017.1348442.
  • Domnich A, Cambiaggi M, Vasco A, Maraniello L, Ansaldi F, Baldo V, Bonanni P, Calabrò GE, Costantino C, de Waure C, et al. Attitudes and beliefs on influenza vaccination during the COVID-19 pandemic: results from a representative Italian survey. Vaccines. 2020;8(4):711. doi:10.3390/vaccines8040711.
  • Lytle KL, Collins SP, Feldstein LR, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, et al. Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020. Vaccine. 2021;39:5271–76. doi:10.1016/j.vaccine.2021.07.057.
  • Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, Vaezjalali M, Hajikhani B. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front. Med. 2021;8:681469. doi:10.3389/fmed.2021.681469.
  • GIMBE Foundation. Report osservatorio GIMBE n. 3/2021 La vaccinazione antinfluenzale in Italia [Internet]. Bologna; 2021 [accessed 2022 Jan 29]. https://www.gimbe.org/osservatorio/Report_Osservatorio_GIMBE_2021.03_Vaccinazione_antinfluenzale_in_Italia.pdf .
  • Regione Lombardia. Informazioni sulla campagna vaccinale [Internet]. 2020 [accessed 2021 Sep 14]. https://www.ats-brescia.it/campagna-vaccinale-antinfluenzale .
  • Nowak SA, Gidengil CA, Parker AM, Matthews LJ. Association among trust in health care providers, friends, and family, and vaccine hesitancy. Vaccine. 2021;39:5737–40. doi:10.1016/j.vaccine.2021.08.035.
  • González-Block MÁ, Pelcastre-Villafuerte BE, Riva Knauth D, Fachel-Leal A, Comes Y, Crocco P, Noboa L, Rodríguez Zea B, Ruoti M, Díaz Portillo SP, et al. Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups. PloS One. 2021;16:e0256040. doi:10.1371/journal.pone.0256040.
  • Hudson A, Montelpare WJ. Predictors of vaccine hesitancy: implications for COVID-19 public health messaging. Int J Environ Res Public Health. 2021;18(15):8054. doi:10.3390/ijerph18158054.
  • Ziello A, Scavone C, di Battista ME, Salvatore S, di Giulio Cesare D, Moreggia O, Allegorico L, Sagnelli A, Barbato S, Manzo V, et al. Influenza vaccine hesitancy in patients with multiple sclerosis: a monocentric observational study. Brain Sci. 2021;11(7):890. doi:10.3390/brainsci11070890.
  • Figueroa-Parra G, Esquivel-Valerio JA, Santoyo-Fexas L, Moreno-Salinas A, Gamboa-Alonso CM, de Leon-Ibarra AL, Galarza-Delgado DA. Knowledge and attitudes about influenza vaccination in rheumatic diseases patients. Hum Vaccines Immunother. 2021;17:1420–25. doi:10.1080/21645515.2020.1816108.
  • Dubé E, Gagnon D, MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. 2015;33:4191–203. doi:10.1016/j.vaccine.2015.04.041.
  • Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF joint reporting form data-2015–2017. Vaccine. 2018;36:3861–67. doi:10.1016/j.vaccine.2018.03.063.
  • Italian Ministry of Health. Vaccinazione antinfluenzale-Confronti coperture nella Popolazione GENERALE al 2020-2021 [Internet]. 1999 [accessed 2022 Jan 24]. https://www.salute.gov.it/imgs/C_17_tavole_19_3_0_file.pdf .
  • Bonanni P, Angelillo IF, Villani A, Biasci P, Scotti S, Russo R, Maio T, Vitali Rosati G, Barretta M, Bozzola E, et al. Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: let’s avoid adding epidemics to the pandemic: appeal from the board of the vaccination calendar for life in Italy: maintain and increase coverage also by re-organizing vaccination services and reassuring the population. Vaccine. 2021;39:1187–89.
  • Gerussi V, Peghin M, Palese A, Bressan V, Visintini E, Bontempo G, Graziano E, de Martino M, Isola M, Tascini C. Vaccine hesitancy among Italian patients recovered from COVID-19 infection towards influenza and Sars-Cov-2 vaccination. Vaccines. 2021;9:172. doi:10.3390/vaccines9020172.
  • Alcusky MJ, Pawasauskas J. Adherence to guidelines for Hepatitis B, Pneumococcal, and influenza vaccination in patients with diabetes. Clin Diabetes. 2015;33:116–22. doi:10.2337/diaclin.33.3.116.
  • Martinez-Huedo MA, Lopez-De-Andrés A, Mora-Zamorano E, Hernández-Barrera V, Jiménez-Trujillo I, Zamorano-Leon JJ, Jiménez-GarcíGarcíA R. Decreasing influenza vaccine coverage among adults with high-risk chronic diseases in Spain from 2014 to 2017. Hum Vaccines Immunother. 2020;16:95–99. doi:10.1080/21645515.2019.1646577.
  • Napolitano F, della Polla G, Capano MS, Augimeri M, Angelillo IF. Vaccinations and chronic diseases: knowledge, attitudes, and self-reported adherence among patients in Italy. Vaccines. 2020;8:560. doi:10.3390/vaccines8040560.
  • Thitilertdecha P, Khowawisetsut L, Ammaranond P, Poungpairoj P, Tantithavorn V, Onlamoon N. Impact of vaccination on distribution of T cell subsets in antiretroviral-treated HIV-infected children. Dis Markers. 2017;2017:1–8. doi:10.1155/2017/5729639.
  • Pasricha N, Datta U, Chawla Y, Singh S, Arora SK, Sud A, Minz RW, Saikia B, Singh H, James I, et al. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine. BMC Infect Dis. 2006;6:65. doi:10.1186/1471-2334-6-65.
  • Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000–2001). J Am Geriatr Soc. 2004;52:25–30. doi:10.1111/j.1532-5415.2004.52006.x.
  • Abramson ZH, Cohen-Naor V. Factors associated with performance of influenza immunization among the elderly. Isr Med Assoc J. 2000;2:902–07.
  • Palache A, Rockman S, Taylor B, Akcay M, Billington JK, Barbosa P. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use. Vaccine. 2021;39:6081–87. doi:10.1016/j.vaccine.2021.08.097.